BHVN Biohaven Pharmaceutical Holding 8-K2021Biohaven Acquires Kleo Pharmaceuticals and Licenses Platform Technology from Yale University to Form Biohaven Labs
8 Jan 21
Files
SEC
Content Analysis
?
| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
|
|
BHVN 8-K Filings
- 8 Jan 21 Biohaven Acquires Kleo Pharmaceuticals and Licenses Platform Technology from Yale University to Form Biohaven Labs
- 23 Dec 20 Other Events
- 9 Nov 20 Biohaven Reports Third Quarter 2020 Financial Results and Recent Business Developments
- 18 Aug 20 Amendments to Articles of Incorporation or Bylaws
Filing View
Search this filing
Table of Contents
Get all this for free
- Email alerts for new filings that match keywords or companies
- Plot, compare & download financial data
- 10-K & 10-Q redlined comparisons
- Advanced filing search & analysis
- Sentiment analysis for financial filings
- Favorites, search history, and more…